NCT02841709 - Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

June 29, 2017

Conditions

Insomnia Disorder

Interventions

DRUG

ACT-541468

Capsules for oral administration containing ACT-541468 at a strength of 5 mg, 10 mg or 25 mg

DRUG

Placebo

Capsules for oral administration matching the ACT-541468 capsules

Trial Locations (10)

Investigator Site, New York

Investigator Site, Berlin

Investigator Site, Berlin

Investigator Site, Schwerin

Investigator Site, Hamburg

Investigator Site, Hanover

Investigator Site, Brandon

Investigator Site, Cincinnati

Investigator Site, Chicago

Investigator Site, Las Vegas